Summit Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	106.52	225.27	104.86	71.43	348.61	71.79
Short-Term Investments	492.22	488.18	307.49	114.82	-	-
Cash & Short-Term Investments	598.73	713.45	412.35	186.24	348.61	71.79
Cash Growth	65.71%	73.02%	121.41%	-46.58%	385.59%	8.09%
Accounts Receivable	-	-	-	-	0.35	1.46
Other Receivables	-	-	0.56	0.85	5.77	15.7
Total Trade Receivables	-	-	0.56	0.85	6.12	17.16
Other Current Assets	17.87	6.85	10.84	2.62	301.99	8.36
Total Current Assets	616.6	720.3	423.75	189.71	656.71	97.31
Net Property, Plant & Equipment	19.4	20.62	7.4	6.06	5.08	3.48
Other Intangible Assets	-	-	-	-	-	10.4
Goodwill	1.97	2	1.86	1.89	1.8	2.01
Other Long-Term Assets	8.23	7.21	2.55	5.28	0.58	0.17
Total Assets	647.86	751.18	435.56	202.95	664.17	113.37
Accounts Payable	27.55	20.29	4.64	2.67	0.36	4.37
Accrued Expenses	51.39	47.03	31.53	14.21	16.31	11.32
Short-Term Debt	-	-	-	-	19.77	-
Current Portion of Leases	3.18	3.39	3.77	2.81	1.69	1.09
Unearned Revenue	-	-	-	-	-	7.94
Other Current Liabilities	1.15	2.28	1.8	0.72	0.66	0.9
Total Current Liabilities	83.27	72.99	41.73	20.41	38.78	25.62
Long-Term Debt	-	-	-	100	494.54	-
Long-Term Leases	16.86	17.5	3.45	3.29	2.76	1.69
Other Long-Term Liabilities	1.8	1.83	1.63	1.56	1.43	2.78
Total Long-Term Liabilities	18.66	19.33	5.08	104.85	498.73	4.47
Total Liabilities	101.92	92.32	46.81	125.26	537.51	30.09
Common Stock	7.76	7.75	7.38	7.02	2.11	0.98
Additional Paid-in Capital	3,024	2,948	1,598	1,066	504.77	384.05
Accumulated Other Comprehensive Income	-2.63	-2.54	-2.29	-2.45	-1.89	-2.2
Retained Earnings	-2,484	-2,294	-1,215	-993.26	-378.33	-299.55
Shareholders' Equity	545.93	658.86	388.75	77.69	126.65	83.28
Total Liabilities & Equity	647.86	751.18	435.56	202.95	664.17	113.37
Total Debt	20.04	20.89	7.22	106.1	518.76	2.78
Net Cash (Debt)	578.69	692.56	405.13	80.14	-170.16	69.01
Net Cash Growth	-16.44%	70.95%	405.51%	-	-	4.63%
Net Cash Per Share	0.76	0.93	0.56	0.13	-0.88	0.52
Book Value	545.93	658.86	388.75	77.69	126.65	83.28
Book Value Per Share	0.72	0.88	0.54	0.13	0.66	0.63
Tangible Book Value	543.97	656.86	386.88	75.8	124.86	70.88
Tangible Book Value Per Share	0.72	0.88	0.54	0.12	0.65	0.54

SEC Filings: 10-K · 10-Q